Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
This Ph.D. training targets a Department of Education “area of national need.”
This finding may point to a therapeutic target to treat tuberculosis, which kills 1.3 million people each year.
An animal model for mild traumatic brain injury shows microscopic neuropathology, as well as neurophysiological and biochemical changes.
Findings show that mitochondrial DNA may strongly influence cellular metabolism and susceptibility to metabolic diseases like heart failure or obesity.
A study of how experimental inhibitors bind a key flu protein may guide novel antiviral compounds.
Yabing Chen, Ph.D., and Ganesh Halade, Ph.D., have won 2018 “best paper” awards.
Ashlyn Burch’s DOE award lets her study at Sandia National Laboratory, Albuquerque, New Mexico.
Platelet blood cells can carry an enzyme needed to prevent clots, while hiding it from autoantibody neutralization.
Pretreatment with the NSAID carprofen before experimental heart attack in mice caused a diminished resolution of acute inflammation.
This knowledge can aid vaccine development, treatment of infections and moderation of autoimmune disease.